436 related articles for article (PubMed ID: 17158352)
21. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of tissue factor expression and thrombogenic activity in human aortic smooth muscle cells by irradiation, rapamycin and paclitaxel.
Eisenreich A; Celebi O; Goldin-Lang P; Schultheiss HP; Rauch U
Int Immunopharmacol; 2008 Feb; 8(2):307-11. PubMed ID: 18182245
[TBL] [Abstract][Full Text] [Related]
23. PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design.
Holy EW; Jakob P; Eickner T; Camici GG; Beer JH; Akhmedov A; Sternberg K; Schmitz KP; Lüscher TF; Tanner FC
Eur Heart J; 2014 Mar; 35(12):808-20. PubMed ID: 24334406
[TBL] [Abstract][Full Text] [Related]
24. Paclitaxel potentiates inflammatory cytokine-induced prothrombotic molecules in endothelial cells.
Wood SC; Tang X; Tesfamariam B
J Cardiovasc Pharmacol; 2010 Mar; 55(3):276-85. PubMed ID: 20075745
[TBL] [Abstract][Full Text] [Related]
25. Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo.
Nordt TK; Sawa H; Fujii S; Bode C; Sobel BE
J Mol Cell Cardiol; 1998 Aug; 30(8):1535-43. PubMed ID: 9737940
[TBL] [Abstract][Full Text] [Related]
26. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent.
Beijk MA; Piek JJ
Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467
[TBL] [Abstract][Full Text] [Related]
27. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription.
Diebold I; Djordjevic T; Hess J; Görlach A
Thromb Haemost; 2008 Dec; 100(6):1021-8. PubMed ID: 19132225
[TBL] [Abstract][Full Text] [Related]
28. Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells.
Nordt TK; Lutzi S; Ruef J; Peter K; Klar E; Kübler W; Sobel BE; Bode C
Thromb Haemost; 2001 Nov; 86(5):1305-13. PubMed ID: 11816722
[TBL] [Abstract][Full Text] [Related]
29. Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells.
Mussoni L; Banfi C; Sironi L; Arpaia M; Tremoli E
Thromb Haemost; 2000 Jul; 84(1):59-64. PubMed ID: 10928471
[TBL] [Abstract][Full Text] [Related]
30. Fluvastatin accelerates re-endothelialization impaired by local sirolimus treatment.
Fukuda D; Enomoto S; Shirakawa I; Nagai R; Sata M
Eur J Pharmacol; 2009 Jun; 612(1-3):87-92. PubMed ID: 19371739
[TBL] [Abstract][Full Text] [Related]
31. Effects of IL-1beta and IL-6 on tissue-type plasminogen activator expression in vascular endothelial cells.
Larsson P; Ulfhammer E; Karlsson L; Bokarewa M; Wåhlander K; Jern S
Thromb Res; 2008; 123(2):342-51. PubMed ID: 18502475
[TBL] [Abstract][Full Text] [Related]
32. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
[TBL] [Abstract][Full Text] [Related]
33. Sirolimus increases tissue factor expression but not activity in cultured human vascular smooth muscle cells.
Zhu S; Viswambharan H; Gajanayake T; Ming XF; Yang Z
BMC Cardiovasc Disord; 2005 Jul; 5():22. PubMed ID: 16018822
[TBL] [Abstract][Full Text] [Related]
34. Recombinant adeno-associated virus vector-transduced vascular endothelial cells express the thrombomodulin transgene under the regulation of enhanced plasminogen activator inhibitor-1 promoter.
Mimuro J; Muramatsu S; Hakamada Y; Mori K; Kikuchi J; Urabe M; Madoiwa S; Ozawa K; Sakata Y
Gene Ther; 2001 Nov; 8(22):1690-7. PubMed ID: 11892836
[TBL] [Abstract][Full Text] [Related]
35. Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center.
Bose R; Gupta G; Grayburn PA; Laible EA; Kang MJ; Choi JW
Am J Cardiol; 2007 Sep; 100(6):949-52. PubMed ID: 17826375
[TBL] [Abstract][Full Text] [Related]
36. Cell-specific expression of uptake transporters--a potential approach for cardiovascular drug delivery devices.
Meyer Zu Schwabedissen HE; Begunk R; Hussner J; Juhnke BO; Gliesche D; Böttcher K; Sternberg K; Schmitz KP; Kroemer HK
Mol Pharm; 2014 Mar; 11(3):665-72. PubMed ID: 24495124
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation.
Stähli BE; Camici GG; Steffel J; Akhmedov A; Shojaati K; Graber M; Lüscher TF; Tanner FC
Circ Res; 2006 Jul; 99(2):149-55. PubMed ID: 16794185
[TBL] [Abstract][Full Text] [Related]
38. Plasminogen activator and plasminogen activator inhibitor gene expression in human saphenous vein organ culture.
Javed Q; Swanson N; Warner EL; Gershlick AH; de Bono DP
Exp Mol Pathol; 2001 Apr; 70(2):146-53. PubMed ID: 11263957
[TBL] [Abstract][Full Text] [Related]
39. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells.
Wojta J; Gallicchio M; Zoellner H; Hufnagl P; Last K; Filonzi EL; Binder BR; Hamilton JA; McGrath K
Thromb Haemost; 1993 Sep; 70(3):469-74. PubMed ID: 8259551
[TBL] [Abstract][Full Text] [Related]
40. Involvement of heat shock factor-1 in glycated LDL-induced upregulation of plasminogen activator inhibitor-1 in vascular endothelial cells.
Zhao R; Shen GX
Diabetes; 2007 May; 56(5):1436-44. PubMed ID: 17259369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
